Netscribes latest market research report titled Coronary Stents Market in India 2014 states that manufacturers of coronary stents are experiencing high demand for their products due to a number of reasons. With cardiovascular diseases becoming a common occurrence amongst Indians and the healthcare infrastructure in the country rapidly improving, the number of angioplasty procedures being carried out in the country has increased significantly. Advancements in technology has resulted in patients being more receptive towards stent implants. The products available in the market can be divided into two types those manufactured by MNCs and commanding high prices, and those manufactured by domestic companies and generally having lower prices. The general perception is that stents manufactured by MNCs are superior in terms of quality and efficacy whereas those manufactured by domestic companies fail to attain similar high quality. As a result, the MNCs serve majority of the market with almost all the big hospitals in tier I cities preferring to implant stents manufactured by foreign companies. Since the medical equipments and devices industry in India has not been given any separate legal status and coronary stents have been classified as drugs under the provisions of the Drugs & Cosmetics Act, 1940, the Central Drugs Standard Control Organization (CDSCO) is responsible for the regulation of stents in the country. The significant reduction in reimbursement rates for stents under the Central Government Health Scheme (CGHS) in Feb 2013 and a further reduction in the reimbursement rates in Apr 2014 has badly affected manufacturers, especially the MNCs. Although majority of the angioplasties performed in the country are done in private establishments with only a few being done under the CGHS, the reduction in the reimbursement rates is likely to force companies to lower price in the open market as well. However, despite a fall in price of products, the market is still expected to grow steadily. Moreover, the penetration of cath labs in the smaller cities and towns has made angioplasty more accessible to patients and is expected to boost demand for stents.

1. Coronary Stents Market in India 2014
Netscribes latest market research report titled Coronary Stents Market in India 2014 states that manufacturers of coronary stents are experiencing high demand for
their products due to a number of reasons. With cardiovascular diseases becoming a common occurrence amongst Indians and the healthcare infrastructure in the
country rapidly improving, the number of angioplasty procedures being carried out in the country has increased significantly. Advancements in technology has
resulted in patients being more receptive towards stent implants. The products available in the market can be divided into two types those manufactured by
MNCs and commanding high prices, and those manufactured by domestic companies and generally having lower prices. The general perception is that stents
manufactured by MNCs are superior in terms of quality and efficacy whereas those manufactured by domestic companies fail to attain similar high quality. As a
result, the MNCs serve majority of the market with almost all the big hospitals in tier I cities preferring to implant stents manufactured by foreign companies.
Since the medical equipments and devices industry in India has not been given any separate legal status and coronary stents have been classified as drugs under
the provisions of the Drugs & Cosmetics Act, 1940, the Central Drugs Standard Control Organization (CDSCO) is responsible for the regulation of stents in the
country. The significant reduction in reimbursement rates for stents under the Central Government Health Scheme (CGHS) in Feb 2013 and a further reduction in
the reimbursement rates in Apr 2014 has badly affected manufacturers, especially the MNCs. Although majority of the angioplasties performed in the country are
done in private establishments with only a few being done under the CGHS, the reduction in the reimbursement rates is likely to force companies to lower price
in the open market as well. However, despite a fall in price of products, the market is still expected to grow steadily. Moreover, the penetration of cath labs in the
smaller cities and towns has made angioplasty more accessible to patients and is expected to boost demand for stents.
Slide 1: Executive Summary
macroeconomic Indicators
slide 2: Gdp At Factor Cost: Quarterly (2010-11, 2011-12, 2012-13, 2013-14), Inflation Rate: Monthly (jul 2013 Dec 2013)
slide 3: Gross Fiscal Deficit: Monthly (feb 2013 Jul 2013), Exchange Rate: Half Yearly (oct 2013 Mar 2014)
slide 4: Lending Rate: Annual (2008-09, 2009-10, 2010-11, 2011-12), Trade Balance: Annual (2010-11, 2011-12, 2012-13, 2013-14), Fdi: Annual (2009-10,
2010-11, 2011-12, 2012-13)
introduction
slide 5: Coronary Stents Uses, Characteristics And Types
slide 6: Development Of Coronary Stents
market Overview
slide 7: Angioplasties Overview And Number Of Procedures Performed In India (2008 2018e)
slide 8: Angioplasties Segmentation (age-wise; 2008 2013 & Gender-wise; 2008 -2013)
slide 9: Angioplasties Segmentation (based On Vessels Treated; 2009 2013 & Segregation Of Centers Based On Number Of Angioplasties Performed Each
Year; 2009, 2010, 2011, 2013)
slide 10: Coronary Stents Market Overview, Market Size & Growth (value-wise; 2012 2018e & Volume-wise; 2012 2018e)
slide 11: Drug-eluting Stents Market Overview, Market Size & Growth (value-wise; 2012 2018e & Volume-wise; 2012 2018e)
slide 12: Bare Metal Stents Market Overview, Market Size & Growth (value-wise; 2012 2018e & Volume-wise; 2012 2018e)
slide 13: Bioabsorbable Stents Market Overview, Market Size & Growth (value-wise; 2013 2018e & Volume-wise; 2013e 2018e)
slide 14: Coronary Stents Price Trends
drivers & Challenges
slide 15: Drivers And Challenges Summary
slide 16-20: Drivers
slide 21-22: Challenges
government Involvement
slide 23: Organizational Structure Of Regulatory Bodies
slide 24-25: Regulatory Bodies
slide 26-29: Regulatory Policies
slide 30: Process Of Obtaining License For Manufacturing Medical Device Regulated As Drugs In India
slide 31-33: Requirements For Grant Of License For Manufacture Of Medical Devices In India
slide 34: Process Of Obtaining Registration For Import Of Medical Device Regulated As Drugs In India
slide 35-39: Documents Required For The Registering Medical Devices For Import Into India
competitive Landscape
slide 40-42: Entry Barriers
slide 43: Porters Five Forces Analysis
slide 44: Competition Overview, Market Share Of Companies (volume-wise; 2013)
slide 45: Sale Of Coronary Stents By Various Companies (2013)
slide 46-49: Competitive Benchmarking
slide 50-98: Major Companies
buyer Details
slide 99: List Of Top 10 Hospitals Buying Coronary Stents In India
slide 100-129: Major Buyers
Coronary Stents Market in India 2014

2. slide 130: Other Major Purchasers Of Stents
recent Developments
slide 131: Major Recent Developments In The Market
strategic Recommendation
slide 132-133: Key Recommendations
slide 134: Opportunities By Geography
appendix
slide 135: Key Ratios Description
slide 136: Sources Of Information
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Coronary Stents Market in India 2014